Could virtual reality ease pain during a common heart procedure?
NCT ID NCT07653763
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether wearing virtual reality glasses during femoral sheath removal — a routine step after a heart catheterization — can lower pain, anxiety, and changes in vital signs. About 60 adults undergoing this procedure will be randomly assigned to either use VR glasses or receive standard care. Researchers will measure pain, anxiety, heart rate, blood pressure, oxygen levels, and body temperature before, during, and after the procedure to see if VR improves comfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Virtual reality glasses
- What this could lead to
- If effective, virtual reality could offer a drug-free way to ease discomfort during a common post-heart-procedure step.
- What could go wrong
- This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The effect may be modest or no better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years and older * Patients undergoing percutaneous coronary intervention via femoral access * Patients with only one femoral sheath catheter * Patients who did not receive analgesic medication before sheath removal * Patients without severe hemorrhage or major hematoma at the femoral sheath site * Patients able to communicate in Turkish * Patients without visual, hearing, or speech impairment * Patients without mental impairment affecting communication * Patients without psychiatric diagnosis and not using psychiatric medication Exclusion Criteria: * Patients unwilling to participate or wishing to withdraw from the study at any stage * Patients who removed the virtual reality glasses during the intervention * Patients who experienced intolerance to virtual reality application (e.g., dizziness or nausea)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
İskenderun Devlet Hastanesi
İskenderun, Hatay, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- New heart scan aims to spot hidden plaque before it strikes
- Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?